Lim JT - Search Results

1

Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors.

Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB. Han EK, et al. Among authors: lim jt. Prostate. 1998 May;35(2):95-101. doi: 10.1002/(sici)1097-0045(19980501)35:2<95::aid-pros2>3.0.co;2-f. Prostate. 1998. PMID: 9568672

2

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB. Suzui M, et al. Among authors: lim jt. Cancer Res. 2002 Jul 15;62(14):3997-4006. Cancer Res. 2002. PMID: 12124333

3

Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.

Han EK, Arber N, Yamamoto H, Lim JT, Delohery T, Pamukcu R, Piazza GA, Xing WQ, Weinstein IB. Han EK, et al. Among authors: lim jt. Breast Cancer Res Treat. 1998 Apr;48(3):195-203. doi: 10.1023/a:1005924730450. Breast Cancer Res Treat. 1998. PMID: 9598866

4

Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells.

Yamamoto H, Soh JW, Shirin H, Xing WQ, Lim JT, Yao Y, Slosberg E, Tomita N, Schieren I, Weinstein IB. Yamamoto H, et al. Among authors: lim jt. Oncogene. 1999 Jan 7;18(1):103-15. doi: 10.1038/sj.onc.1202269. Oncogene. 1999. PMID: 9926925

5

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, Buttyan R, Yamamoto H, Sperl GJ, Brendel K, Gross PH, Pamukcu R, Weinstein IB. Lim JT, et al. Biochem Pharmacol. 1999 Oct 1;58(7):1097-107. doi: 10.1016/s0006-2952(99)00200-2. Biochem Pharmacol. 1999. PMID: 10484067 Free article.

6

Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.

Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Masuda M, et al. Among authors: lim jt. J Exp Ther Oncol. 2002 Nov-Dec;2(6):350-9. doi: 10.1046/j.1359-4117.2002.01062.x. J Exp Ther Oncol. 2002. PMID: 12440226

7

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

Masuda M, Suzui M, Lim JT, Weinstein IB. Masuda M, et al. Among authors: lim jt. Clin Cancer Res. 2003 Aug 15;9(9):3486-91. Clin Cancer Res. 2003. PMID: 12960141

8

Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.

Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB. Lim JT, et al. Clin Cancer Res. 2003 Oct 15;9(13):4972-82. Clin Cancer Res. 2003. PMID: 14581372

9

Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells.

Shimizu M, Suzui M, Deguchi A, Lim JT, Weinstein IB. Shimizu M, et al. Among authors: lim jt. Clin Cancer Res. 2004 Feb 1;10(3):1130-40. doi: 10.1158/1078-0432.ccr-0714-3. Clin Cancer Res. 2004. PMID: 14871993

10

Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.

Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB. Suzui M, et al. Among authors: lim jt. Mol Cancer Ther. 2004 Mar;3(3):309-16. Mol Cancer Ther. 2004. PMID: 15026551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters